NR1H4 and metabolic dysfunction-associated steatohepatitis: In summary, our study highlighted the mechanisms of BBR on modulating gut microbiota and BA metabolism, and the subsequent activation of intestinal FXR in promoting FGF15 production to alleviate NASH in mice.